OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
3-(Benzo[d]thiazol-2-yl)-4-aminoquinoline derivatives as novel scaffold topoisomerase I inhibitor via DNA intercalation: design, synthesis, and antitumor activities
Jing‐Mei Yuan, Nan‐Ying Chen, Hao-Ran Liao, et al.
New Journal of Chemistry (2020) Vol. 44, Iss. 26, pp. 11203-11214
Closed Access | Times Cited: 12
Jing‐Mei Yuan, Nan‐Ying Chen, Hao-Ran Liao, et al.
New Journal of Chemistry (2020) Vol. 44, Iss. 26, pp. 11203-11214
Closed Access | Times Cited: 12
Showing 12 citing articles:
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets
Antonino Lauria, Gabriele La Monica, Alessia Bono, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113555-113555
Closed Access | Times Cited: 63
Antonino Lauria, Gabriele La Monica, Alessia Bono, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113555-113555
Closed Access | Times Cited: 63
Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity
Mostafa M. Elbadawi, Wagdy M. Eldehna, Wenjie Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113261-113261
Open Access | Times Cited: 42
Mostafa M. Elbadawi, Wagdy M. Eldehna, Wenjie Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113261-113261
Open Access | Times Cited: 42
DNA intercalators as anticancer agents
Sneha Venugopal, Vikas Sharma, Anuradha Mehra, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 4, pp. 580-598
Closed Access | Times Cited: 27
Sneha Venugopal, Vikas Sharma, Anuradha Mehra, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 4, pp. 580-598
Closed Access | Times Cited: 27
Exploring diverse frontiers: Advancements of bioactive 4-aminoquinoline-based molecular hybrids in targeted therapeutics and beyond
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116043-116043
Closed Access | Times Cited: 19
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116043-116043
Closed Access | Times Cited: 19
New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies
Ulviye Acar Çevik, Betül Kaya, İsmail Çeli̇k, et al.
ACS Omega (2024)
Open Access | Times Cited: 5
Ulviye Acar Çevik, Betül Kaya, İsmail Çeli̇k, et al.
ACS Omega (2024)
Open Access | Times Cited: 5
Design, Synthesis and Bioactive Evaluation of Topo I/c-MYC Dual Inhibitors to Inhibit Oral Cancer via Regulating the PI3K/AKT/NF-κB Signaling Pathway
Bin Zheng, Yixiao Wang, Ziyan Wu, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 894-894
Open Access
Bin Zheng, Yixiao Wang, Ziyan Wu, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 894-894
Open Access
Rutaecarpine analogues with potent anti-inflammation to alleviate acute ulcerative colitis via regulating TLR4/MAPK/NF-κB pathway
Li-Qing Qin, Zi-Yu Gu, Nan‐Ying Chen, et al.
Results in Chemistry (2024) Vol. 7, pp. 101330-101330
Open Access | Times Cited: 4
Li-Qing Qin, Zi-Yu Gu, Nan‐Ying Chen, et al.
Results in Chemistry (2024) Vol. 7, pp. 101330-101330
Open Access | Times Cited: 4
Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions
Ramakant A. Kardile, Aniket P. Sarkate, Avinash S. Borude, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105174-105174
Closed Access | Times Cited: 22
Ramakant A. Kardile, Aniket P. Sarkate, Avinash S. Borude, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105174-105174
Closed Access | Times Cited: 22
Benzothiazole‐based apoptosis inducers: A comprehensive overview and future prospective
Payal Kamboj, Anjali Mahore, Asif Husain, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 4
Closed Access | Times Cited: 1
Payal Kamboj, Anjali Mahore, Asif Husain, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 4
Closed Access | Times Cited: 1
Design and synthesis of luotonin A-derived topoisomerase targeting scaffold with potent antitumor effect and low genotoxicity
Xinwei Li, Shu-Jun Fang, Ying-Ze Li, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107015-107015
Closed Access | Times Cited: 4
Xinwei Li, Shu-Jun Fang, Ying-Ze Li, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107015-107015
Closed Access | Times Cited: 4
Thiazole, Isatin and Phthalimide Derivatives Tested in vivo against Cancer Models: A Literature Review of the Last Six Years
Aline Ferreira Pinto, Janine Siqueira Nunes, José Eduardo Severino Martins, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 20, pp. 2991-3032
Closed Access | Times Cited: 3
Aline Ferreira Pinto, Janine Siqueira Nunes, José Eduardo Severino Martins, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 20, pp. 2991-3032
Closed Access | Times Cited: 3
A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle
Yongqi Li, Dawei Zhao, Wenqiu Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Yongqi Li, Dawei Zhao, Wenqiu Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
